REFERENCES
- Olopade O. The emerging role of genetics in clinical cancer care. In: Perry MC, Whippen D, Harrington R, American Society of Clinical Oncology educational book, 34th annual meeting, Los Angeles, May 16–19, 1998. American Society of Clinical Oncology, Alexandria, VA, 1998: 210–6.
- Wilkie T. Genetics and insurance in Britain: why more than just the Atlantic divides the English-speaking nations. Nat Genet 1998; 20: 119–21.
- Hudson KL, Rothenberg KH, Andrews LB, et al. Genetic discrimination and health insurance: an urgent need for re-form. Science 1995; 270: 391–3.
- Association of British Insurers. Information sheet. Life in-surance and genetics. London, United Kingdom, ABI, 1997.
- Norwegian Ministry of Health and Social Affairs. The law of 5th of August 1994, no. 56 about the medical use of biotech-nology. Oslo 1994.
- Norwegian Breast Cancer Group. Breast cancer, diagnosis and treatment. The Norwegian Cancer Union, Oslo, 1994.
- The council for the consideration of medical technology. Colorectal cancer and heritage. NAVF, Oslo 1992.
- Vase HFA, Mecklin JP, Meera Kahn P, Lynch HT. Heredi-tary non-polyposis colorectal cancer. Lancet 1991; 338: 877.
- Garber J. A summary of breast and colon cancer genetics. In: Perry MC, Whippen D, Harrington R. American Society of Clinical Oncology. Educational book. 34th annual meeting, Los Angeles, May 16–19, 1998. American Society of Clinical Oncology, Alexandria VA, 1998: 217–21.
- Easton DF, Bishop DT, Ford D, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer. Results from 214 families. Am J Hum Genet 1993; 52: 678–701.
- Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336: 1401–8.